139.00
-0.71%
Close of 9 Nov 2026, in TWD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Delta Asia International
Its shares trade on Taipei Exchange under the ticker 6762.TWO. It has been listed since 18 December 2019. In the fiscal year to 31 December 2025, it reported revenue of TWD 694.2m and net income of TWD 23.4m. At that date it held total assets of TWD 2.81bn and shareholders' equity of TWD 1.31bn.
Delta Asia International Corp. engages in manufacture of medical devices. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2019-12-18. The firm's products are mainly used in cardiovascular minimally invasive surgical equipment, abdominal cavity minimally invasive surgical equipment, disposable surgical robotic equipment, blood glucose monitoring portable devices, automated insulin delivery systems, physiological monitoring portable devices, safety syringes and orthopedic surgical equipment. The firm operates primarily in the Americas and Asia.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 18 Dec 2019
- Employees
- 134
- Website
- deltaasia.com.tw ↗
Leadership
Pay as last reported
- Ms. Yawen XuChairman of the Board, General Manager, since 2004
- Mr. Hongwen WeiDeputy General Manager, Director, since 2017
- Weilun LinHead of Finance & Accounting, Corporate Governance Officer
- Mr. Zhicheng ZhangDirector
- Ms. Cheng-Wen LeeIndependent Director
- Ms. Qiying QiuIndependent Director
- Mr. Juk Ling TingIndependent Director
- Ms. Suzhen YangIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Delta Asia International Corp. manufactures cardiovascular minimally invasive surgical equipment in Taoyuan, Taiwan.
- The company's products include blood glucose monitoring portable devices and automated insulin delivery systems.
- Delta Asia International Corp. operates in the Americas and Asia with 134 employees.
Weaknesses
- Delta Asia International Corp. has a limited workforce of 134 employees in the Health Care sector.
- The company's product range is focused on medical devices with no mention of expansion plans.
- Delta Asia International Corp. is listed on the stock market since 2019 with no recent IPO activity.
Opportunities
- Delta Asia International Corp. can expand its market presence in the Americas and Asia for medical devices.
- The growing demand for minimally invasive surgical equipment presents opportunities for the company.
- Health Care sector growth in Asia offers potential for Delta Asia International Corp. to increase sales.
Threats
- Delta Asia International Corp. faces competition from other Health Care companies in the Americas and Asia.
- The Health Care industry is subject to regulatory changes that could impact operations.
- Economic downturns in the Americas and Asia may reduce demand for medical devices.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.